AKTX
Price
$1.15
Change
+$0.02 (+1.79%)
Updated
Jul 10 closing price
Capitalization
36.25M
APVO
Price
$3.01
Change
-$0.03 (-0.99%)
Updated
Jul 10 closing price
Capitalization
8.71M
Interact to see
Advertisement

AKTX vs APVO

Header iconAKTX vs APVO Comparison
Open Charts AKTX vs APVOBanner chart's image
Akari Therapeutics
Price$1.15
Change+$0.02 (+1.79%)
Volume$6.17K
Capitalization36.25M
Aptevo Therapeutics
Price$3.01
Change-$0.03 (-0.99%)
Volume$135.95K
Capitalization8.71M
AKTX vs APVO Comparison Chart in %
Loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKTX vs. APVO commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a StrongBuy and APVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (AKTX: $1.14 vs. APVO: $3.01)
Brand notoriety: AKTX and APVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 31% vs. APVO: 2%
Market capitalization -- AKTX: $36.25M vs. APVO: $8.71M
AKTX [@Biotechnology] is valued at $36.25M. APVO’s [@Biotechnology] market capitalization is $8.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileAPVO’s FA Score has 1 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • APVO’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKTX and APVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 4 TA indicator(s) are bullish while APVO’s TA Score has 3 bullish TA indicator(s).

  • AKTX’s TA Score: 4 bullish, 4 bearish.
  • APVO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both AKTX and APVO are a good buy in the short-term.

Price Growth

AKTX (@Biotechnology) experienced а -2.14% price change this week, while APVO (@Biotechnology) price change was -0.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

AKTX is expected to report earnings on Apr 15, 2025.

APVO is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKTX($36.2M) has a higher market cap than APVO($8.71M). AKTX YTD gains are higher at: -6.148 vs. APVO (-96.508). AKTX has higher annual earnings (EBITDA): -17.63M vs. APVO (-23.79M). AKTX has more cash in the bank: 2.58M vs. APVO (2.14M). AKTX has less debt than APVO: AKTX (1.85M) vs APVO (4.42M). AKTX (0) and APVO (0) have equivalent revenues.
AKTXAPVOAKTX / APVO
Capitalization36.2M8.71M416%
EBITDA-17.63M-23.79M74%
Gain YTD-6.148-96.5086%
P/E RatioN/A0.00-
Revenue00-
Total Cash2.58M2.14M121%
Total Debt1.85M4.42M42%
FUNDAMENTALS RATINGS
AKTX vs APVO: Fundamental Ratings
AKTX
APVO
OUTLOOK RATING
1..100
892
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6498
P/E GROWTH RATING
1..100
861
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APVO's Valuation (10) in the Biotechnology industry is significantly better than the same rating for AKTX (82) in the Pharmaceuticals Major industry. This means that APVO’s stock grew significantly faster than AKTX’s over the last 12 months.

APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AKTX (100) in the Pharmaceuticals Major industry. This means that APVO’s stock grew similarly to AKTX’s over the last 12 months.

AKTX's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as APVO (100) in the Biotechnology industry. This means that AKTX’s stock grew similarly to APVO’s over the last 12 months.

AKTX's Price Growth Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for APVO (98) in the Biotechnology industry. This means that AKTX’s stock grew somewhat faster than APVO’s over the last 12 months.

AKTX's P/E Growth Rating (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for APVO (61) in the Biotechnology industry. This means that AKTX’s stock grew somewhat faster than APVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AKTXAPVO
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURI4.660.07
+1.53%
CuriosityStream
AREN6.220.02
+0.32%
Arena Group Holdings (The)
HR16.190.05
+0.31%
Healthcare Realty Trust
DEO105.490.30
+0.29%
Diageo plc
GENI10.49-0.39
-3.58%
Genius Sports Limited

AKTX and

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
+2.14%
KPRX - AKTX
30%
Poorly correlated
+1.35%
DSGN - AKTX
24%
Poorly correlated
-3.12%
MOLN - AKTX
23%
Poorly correlated
-0.84%
GLTO - AKTX
23%
Poorly correlated
+2.06%
APVO - AKTX
22%
Poorly correlated
-0.99%
More

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-0.99%
GOSS - APVO
42%
Loosely correlated
N/A
ENLV - APVO
39%
Loosely correlated
+3.08%
AXON - APVO
33%
Loosely correlated
-9.04%
GNPX - APVO
30%
Poorly correlated
+2.76%
KROS - APVO
30%
Poorly correlated
+1.05%
More